Linyu Li

Linyu Li

Auto-generated profile, based on publicly available information

Linyu Li

Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Stroke
Verified
Journal Article
Closed access
JMJian Miao
Jian Miao
HSHongfei Sang
Hongfei Sang
FLFengli Li
Fengli Li
JSJeffrey L Saver
Jeffrey L Saver
BLBo Lei
Bo Lei
SWShaojun Wang
Shaojun Wang
Background: The effect of imaging selection paradigms on endovascular thrombectomy outcomes in patients with acute ischemic stroke with large vessel occlusion remains uncertain. The study aimed to assess the effect of basic imaging (noncontrast computed tomography with or without computed tomographic angiography) versus advanced imaging (magnetic resonance imaging or computed tomography perfusion) on clinical outcomes following thrombectomy in patients with stroke with large vessel occlusion in the early and extended windows using a pooled analysis of patient-level data from 2 pivotal randomized clinical trials done in China. Methods: This post hoc analysis used data from 1182 patients included in 2 multicenter, randomized controlled trials in China that evaluated adjunct therapies to endovascular treatment for acute ischemic stroke (Direct Endovascular Treatment for Large Artery Anterior Circulation Stroke performed from May 20, 2018, through May 2, 2020, and Intravenous Tirofiban Before Endovascular Treatment in Stroke from October 10, 2018, through October 31, 2021). Patients with occlusion of the intracranial internal carotid artery or proximal middle cerebral artery (M1/M2 segments) were categorized according to baseline imaging modality (basic versus advanced) as well as treatment time window (early, 0–6 hours versus extended, 6–24 hours from last known well to puncture). The primary outcome was the proportion of patients with functional independence (modified Rankin Scale score of 0–2) at 90 days. Multivariable Poisson regression analysis was performed to determine the association between imaging selection modality and outcomes after endovascular treatment at each time windows. Results: A total of 1182 patients were included in this cohort analysis, with 648 in the early (471 with basic imaging versus 177 advanced imaging) and 534 in the extended (222 basic imaging versus 312 advanced imaging) time window. There were no differences in 90-day functional independence between the advanced and basic imaging groups in either time windows (early window: adjusted relative risk, 0.99 [95% CI, 0.84–1.16]; P =0.91; extended window: adjusted relative risk, 1.00 [95% CI, 0.84–1.20]; P =0.97). Conclusions: In this post hoc analysis of 2 randomized clinical trial pooled data involving patients with large vessel occlusion stroke, an association between imaging selection modality and clinical or safety outcomes for patients undergoing thrombectomy in either the early or extended windows was not detected. Our study adds to the growing body of literature on simpler imaging paradigms to assess thrombectomy eligibility across both the early and extended time windows. Registration: URL: http://www.chictr.org.cn ; Unique identifiers: ChiCTR-IOR-17013568 and ChiCTR-INR-17014167.

8 May 2024 in International Journal of Surgery
Verified
Journal Article
Open access
CGChangwei Guo
Changwei Guo
LLLinyu Li
Linyu Li
JHJiandi Huang
Jiandi Huang
JYJie Yang
Jie Yang
JSJiaxing Song
Jiaxing Song
WZWenjie Zi
Wenjie Zi
Background: Previous trials confirmed the benefit of endovascular treatment (EVT) in acute large core stroke, but the effect of EVT on outcomes in these patients based on noncontrast computed tomography (NCCT) in real-world clinical practice was unclear. The aim of this study was to explore the effect of EVT versus standard medical treatment (SMT) in patients with large ischemic core stroke defined as Alberta Stroke Program Early CT Score (ASPECTS) ≤5 based on NCCT alone. Materials and methods: Patients with acute large core stroke at 38 Chinese centers between November 2021 and February 2023 were reviewed from a prospectively maintained database. The primary outcome was favorable functional outcome [modified Rankin Scale score (mRS), 0–3] at 90 days. Safety outcomes included 48 h symptomatic intracerebral hemorrhage (sICH) and 90-day mortality. Results: Of 745 eligible patients recruited at 38 stroke centers between November 2021 and February 2023, 490 were treated with EVT+SMT and 255 with SMT alone. One hundred and eighty-one (36.9%) in the EVT group achieved favorable functional independence versus 48 (18.8%) treated with SMT only [adjusted risk ratio (RR), 1.86; 95% CI: 1.43–2.42, P<0.001; adjusted risk difference (RD), 13.77; 95% CI: 7.40–20.15, P<0.001]. The proportion of sICH was significantly higher in patients undergoing EVT (13.3 vs. 2.4%; adjusted RR, 5.17; 95% CI: 2.17–12.32, P<0.001; adjusted RD, 10.10; 95% CI: 6.12–14.09, P<0.001). No significant difference of mortality between the groups was observed (41.8 vs. 49.0%; adjusted RR, 0.91; 95% CI: 0.77–1.07, P=0.24; adjusted RD, −5.91; 95% CI: −12.91–1.09, P=0.1). Conclusion: Among patients with acute large core stroke based on NCCT in real-world, EVT is associated with better functional outcomes at 90 days despite of higher risk of sICH. Rates of procedure-related complications were relatively higher in the EVT+SMT group.

1 January 2022 in Stroke
Verified
Journal Article
Closed access
PDF file
FLFengli Li
Fengli Li
HSHongfei Sang
Hongfei Sang
JSJiaxing Song
Jiaxing Song
ZGZhangbao Guo
Zhangbao Guo
SLShuai Liu
Shuai Liu
FIfor the BASILAR Investigators
for the BASILAR Investigators
Background and Purpose: The BASILAR registry, a nationwide prospective nonrandomized study conducted in China, enrolled consecutive patients with acute basilar artery occlusion receiving endovascular treatment or conventional-treatment from January 2014 to May 2019. This article aimed to report the results of clinical follow-up at one year among these patients. Methods: The primary outcome was the modified Rankin Scale at one year, assessed as a common odds ratio using ordinal logistic regression analysis adjusted for prespecified prognostic factors. Secondary outcomes included the modified Rankin Scale-based outcome group at one year (0–1, 0–2, or 0–3) and all-cause death. Results: Of the 829 patients enrolled in the original BASILAR registry, one-year data were available for 785 patients (94.7%). The distribution of outcomes on the modified Rankin Scale favored endovascular treatment over conventional-treatment (adjusted common odds ratio, 4.50 [95% CI, 2.81–7.29]; P <0.001). The cumulative one-year mortality rate was 54.6% in the endovascular treatment group versus 83.5% in the conventional-treatment group (adjusted odds ratio, 4.36 [95% CI, 2.69–7.29]; P <0.001). Conclusions: The beneficial effect of endovascular treatment on functional outcome at one year in patients with acute basilar artery occlusion is similar to that reported at 90 days in the original study. REGISTRATION: URL: http://www.chictr.org.cn ; Unique identifier: ChiCTR1800014759.

7 August 2025 in International Journal of Surgery
Verified
Journal Article
Open access
GLGuojian Liu
Guojian Liu
HZHaoxuan Zhu
Haoxuan Zhu
LLLinyu Li
Linyu Li
JYJie Yang
Jie Yang
XSXiaolei Shi
Xiaolei Shi
WZWenjie Zi
Wenjie Zi
Background: The specific association of collateral status on outcomes in patients with large ischemic stroke (ASPECTS ≤ 5) remains unclear. This study aimed to investigate the association between collateral status and outcomes in patients who received endovascular therapy (EVT) and assess whether collateral status modifies the effectiveness of bridging intravenous thrombolysis (IVT) before EVT. Materials and methods: This subanalysis of a prospective cohort study enrolled patients with large vessel occlusion and ASPECTS 0–5 from 38 stroke centers across China between November 2021 and February 2023. Collateral status was graded using the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR). The primary outcome was favorable functional outcomes at 90 days (defined as modified Rankin Scale [mRS] scores of 0–3). Safety outcomes included the incidence of symptomatic intracranial hemorrhage (ICH) within 48 h, mortality within 90 days, and any ICH within 48 h. Results: Among 490 patients who received EVT, 34.5% (169 of 490) achieved moderate collateral and 16.7% (82 of 490) achieved good collateral. Compared to patients with poor collateral, good and moderate collateral were associated with higher odds of favorable functional outcomes and reduced rates of ICH and mortality. The effectiveness of bridging IVT prior to EVT was modified by collateral status ( p for interaction = 0.039). Specifically, in patients with moderate collateral, IVT prior to EVT was associated with higher odds of favorable functional improvement (adjusted OR: 2.387, 95% CI: 1.052–5.416, P = 0.037). Conclusion: In patients with large ischemic stroke undergoing EVT, good collateral status was associated with favorable functional outcomes, while those with moderate collateral may benefit from bridging therapy.

11 October 2022 in Cerebrovascular Diseases
Verified
Journal Article
Open access
PDF file
JHJiacheng Huang
Jiacheng Huang
MWMaolin Wang
Maolin Wang
FLFengli Li
Fengli Li
WKWeilin Kong
Weilin Kong
DLDa Liu
Da Liu
QYQingwu Yang
Qingwu Yang
Background: Acute ischemic stroke due to basilar artery occlusion (BAO) is associated with the highest mortality in patients with large vessel occlusion. This study aimed to identify modifiable risk factors of early mortality in patients with BAO. Methods and Results: This was a cohort study of consecutive patients with BAO admitted to 47 stroke centers in China between January 2014 and May 2019. The primary outcome was all-cause mortality within 7 days after hospitalization. Of 829 patients, 164 died (0–3 days: 115; 4–7 days: 49) within 7 days after hospitalization. Among pre- and periprocedural variables, higher admission National Institutes of Health Stroke Scale (NIHSS, adjusted OR, 1.06, 95% CI: 1.04–1.09; p < 0.001), lower admission posterior circulation-Alberta Stroke Program Early Computed Tomography Score (pc-ASPECTS, adjusted OR, 0.88, 95% CI: 0.79–0.98; p = 0.02), lower Basilar Artery on Computed Tomography Angiography score (BATMAN, adjusted OR, 0.84, 95% CI: 0.76–0.93; p = 0.001), and recanalization failure (adjusted OR, 2.99, 95% CI: 2.04–4.38; p < 0.001) were independently associated with a higher risk of early mortality. Herniation (adjusted OR, 2.84, 95% CI: 1.52–5.30; p = 0.001) is an independent postprocedural predictor of early mortality. In patients dying ≤3 days, higher NIHSS (p < 0.001), lower pc-ASPECTS (p = 0.01), lower BATMAN (p = 0.004), recanalization failure (p < 0.001), herniation (p = 0.001), gastrointestinal hemorrhage (p = 0.046), and absence of pneumonia (p < 0.001) were independent predictors of early mortality. Higher NIHSS (p = 0.01), recanalization failure (p < 0.001), and pneumonia (p = 0.03) were independently associated with early mortality between 4 and 7 days. Conclusions: Recanalization failure, herniation, gastrointestinal hemorrhage, and pneumonia are potentially modifiable risk factors for early mortality in basilar artery occlusion.

22 October 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
ZQZhongming Qiu
Zhongming Qiu
FLFengli Li
Fengli Li
DXDongjing Xie
Dongjing Xie
GYGuangxiong Yuan
Guangxiong Yuan
Thanh N NguyenThanh N Nguyen
Thanh N Nguyen
TIthe BRIDGE‐TNK investigators
the BRIDGE‐TNK investigators
Background: Six randomized trials have not detected a difference between intravenous alteplase plus endovascular thrombectomy and endovascular thrombectomy alone in stroke. Tenecteplase, a recombinant human tenecteplase tissue‐type plasminogen activator, is a genetically modified variant of alteplase. It is unclear whether the outcomes are different if alteplase is replaced with tenecteplase. This trial aims to determine whether intravenous tenecteplase within 4.5 hours of time last known well confers benefit in patients with acute ischemic stroke with large‐vessel occlusion who undergo endovascular thrombectomy. Methods: BRIDGE‐TNK (Thrombectomy With Versus Without rhTNK‐tPA in Stroke) is an investigator‐initiated, multicenter, prospective, randomized, open‐label trial with blinded end point evaluation conducted at 40 thrombectomy‐capable centers in China. This trial will randomize 544 patients with intravenous thrombolysis–eligible stroke (272 in each arm) with large‐vessel occlusion within 4.5 hours of last known well to receive bridging intravenous tenecteplase with endovascular thrombectomy (tenecteplase‐plus‐thrombectomy group) or endovascular thrombectomy alone (thrombectomy‐alone group). The primary outcome is the proportion of patients achieving functional independence, defined as a score of 0 to 2 on the modified Rankin Scale, at 90 days. Safety will be assessed via symptomatic intracranial hemorrhage at 48 hours and death at 90 days. Conclusions: BRIDGE‐TNK will provide important data on the role of intravenous tenecteplase before endovascular thrombectomy in patients with acute ischemic stroke with large‐vessel occlusion who can be treated within 4.5 hours of last known well. Registration: URL: https://clinicaltrials.gov . Unique identifier: NCT04733742.